A detailed history of T. Rowe Price Investment Management, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,807,287 shares of PRME stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,807,287
Previous 3,725,727 2.19%
Holding current value
$11.4 Million
Previous $19.2 Million 23.06%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.41 - $6.7 $278,119 - $546,452
81,560 Added 2.19%
3,807,287 $14.7 Million
Q2 2024

Aug 14, 2024

BUY
$4.3 - $8.03 $2.73 Million - $5.1 Million
635,644 Added 20.57%
3,725,727 $19.2 Million
Q1 2024

May 15, 2024

BUY
$6.35 - $9.39 $19.6 Million - $29 Million
3,090,083 New
3,090,083 $21.6 Million

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $286M
More about PRME
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.